Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...

Mediar Therapeutics has dosed the first subject in the Phase II WISPer trial of its investigational therapy, MTX-463, for IPF ...

Stem cells can fight disease from the inside out. But spas and clinics are selling treatments that are unproven, expensive, ...

US Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly claimed in public statements that most vaccines recommended for children in the US have not been tested against placebos, ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Losing body fat involves a combination of approaches, such as eating a lot of protein and spending time on certain workouts.

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Separating Real Mitolyn Reviews From Growing Online Hype - A Data-Driven Safety Breakdown For 2025 Consumers Concerned About Quality And Side Effects PHILADELPHIA, NY / ACCESS Newswire / June 6, 2025 ...

BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...